CHDI Foundation, Inc. is a privately-funded non-profit biomedical research organization that is exclusively dedicated to collaboratively developing therapeutics that substantially improve the lives of those affected by Huntington's disease. As a collaborative enabler CHDI seeks to bring the right partners together to identify and address critical scientific issues and move drug candidates to clinical evaluation as quickly as possible. Our scientists work closely with a network of more than 700 researchers in academic and industrial laboratories around the world in the pursuit of these novel therapies, providing strategic scientific direction to ensure that our common goals remain in focus.
Looking for a particular CHDI employee's phone or email?
The CHDI annual revenue was $16.6 million in 2026.
Robi Blumenstein is the President of CHDI.
17 people are employed at CHDI.
CHDI is based in New York, New York.
The NAICS codes for CHDI are [81341, 8134, 81, 813410, 813].
The SIC codes for CHDI are [86, 864].